NOX 0.00% 6.9¢ noxopharm limited

Ann: Pre-Clinical Breakthrough Discovery Set to Expand Pipeline, page-10

  1. RBx
    643 Posts.
    lightbulb Created with Sketch. 1002
    I agree that 'breakthrough' is a premature description if the reader thinks that it applies to pre-clinical drugs targeting pancreatic and gallbladder cancers.

    I respectfully suggest, however, that the breakthrough in this case refers to the ability to retard the Phase 2 metabolism process.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
6.9¢
Change
0.000(0.00%)
Mkt cap ! $20.16M
Open High Low Value Volume
7.2¢ 7.2¢ 6.9¢ $591 8.493K

Buyers (Bids)

No. Vol. Price($)
1 60978 6.9¢
 

Sellers (Offers)

Price($) Vol. No.
7.2¢ 47310 2
View Market Depth
Last trade - 15.07pm 30/07/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.